Increased patent protection required by the TRIPS has had an impact on access to essential medicines, especially in the developing world. The extent to which such countries can use the flexibilities in the Agreement to promote access to medicines is not clear. This thesis examines whether the TRIPS does actually impede access to medicines.
Prenumerera på vårt nyhetsbrev för att få fantastiska erbjudanden och inspiration för din nästa läsning.
Genom att registrera dig accepterar du vår personuppgiftspolicy.